Evolve Global Healthcare Enhanced Yield Fund (TSX:LIFE)
Assets | 209.89M |
Expense Ratio | 0.74% |
PE Ratio | 20.11 |
Dividend (ttm) | 2.28 |
Dividend Yield | 12.06% |
Ex-Dividend Date | Sep 29, 2025 |
Payout Frequency | Monthly |
Payout Ratio | 244.23% |
1-Year Return | -1.98% |
Volume | 7,095 |
Open | 18.71 |
Previous Close | 18.83 |
Day's Range | 18.71 - 18.84 |
52-Week Low | 17.24 |
52-Week High | 22.23 |
Beta | 1.03 |
Holdings | 89 |
Inception Date | Oct 25, 2017 |
About LIFE
Evolve Global Healthcare Enhanced Yield Fund is an exchange traded fund launched and managed by Evolve Funds Group Inc. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across health care sectors. The fund uses derivatives such as options to create its portfolio. It invests in growth and value stocks of large-cap companies. The fund seeks to track the performance of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged. Evolve Global Healthcare Enhanced Yield Fund was formed on October 24, 2017 and is domiciled in Canada.
Performance
LIFE had a total return of -1.98% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.90%.
Top 10 Holdings
132.03% of assetsName | Symbol | Weight |
---|---|---|
Canadian Dollar | n/a | 84.08% |
Thermo Fisher Scientific Inc. | TMO | 5.73% |
AstraZeneca PLC | AZN | 5.61% |
Johnson & Johnson | JNJ | 5.54% |
AbbVie Inc. | ABBV | 5.42% |
EssilorLuxottica Société anonyme | ESLOY | 5.27% |
Novartis AG ADR | NVSN.MX | 5.19% |
Gilead Sciences, Inc. | GILD | 5.08% |
Boston Scientific Corporation | BSX | 5.06% |
Danaher Corporation | DHR | 5.05% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Sep 29, 2025 | 0.190 CAD | Oct 8, 2025 |
Aug 29, 2025 | 0.190 CAD | Sep 8, 2025 |
Jul 31, 2025 | 0.190 CAD | Aug 8, 2025 |
Jun 30, 2025 | 0.190 CAD | Jul 8, 2025 |
May 30, 2025 | 0.190 CAD | Jun 6, 2025 |
Apr 30, 2025 | 0.190 CAD | May 7, 2025 |